Abbvie is Buying Botox-Maker Allergan in a $63 Billion Pharma Mega-Deal

...have the opportunity to make even bigger contributions to global health than either can alone," said Allergan CEO Brent Saunders. News of the deal, which is slated to close in early 2020, sent shares in Allergan up 33% i...
Read Full Article